Compare CPHI & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPHI | OPAL |
|---|---|---|
| Founded | N/A | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 63.4M |
| IPO Year | 2008 | 2021 |
| Metric | CPHI | OPAL |
|---|---|---|
| Price | $1.15 | $2.41 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.72 |
| AVG Volume (30 Days) | ★ 9.8M | 207.4K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 650.00 |
| EPS | ★ N/A | N/A |
| Revenue | $4,144,268.00 | ★ $348,975,000.00 |
| Revenue This Year | N/A | $12.84 |
| Revenue Next Year | N/A | $9.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.34 |
| 52 Week Low | $0.38 | $1.65 |
| 52 Week High | $19.19 | $2.87 |
| Indicator | CPHI | OPAL |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | N/A |
| Support Level | $0.84 | N/A |
| Resistance Level | $1.22 | N/A |
| Average True Range (ATR) | 1.64 | 0.00 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 1.78 | 0.00 |
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
OPAL Fuels Inc is a fully integrated leader in the capture and conversion of biogas into low-carbon-intensity renewable natural gas and Renewable Power. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-decarbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas. The Company has three operating segments: RNG Fuel, Fuel Station Services, and Renewable Power.